Latest filing published 18 Feb 2026 for Penumbra Inc.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Surbhi Sarna is a declared insider at 2 companies (board member); the most frequent names are Penumbra Inc and Biora Therapeutics, Inc. Over a trading history stretching from 1 July 2019 to 13 February 2026, the count stands at 25 filings.
On the market, this insider has only sold: 13 sales, €383k in total. The rest of the record consists of 11 share grants.
On 18 February 2026 came the latest disclosure, a share grant in Penumbra Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations